Cellular and molecular events leading to renal tubulointerstitial fibrosis

Medical Electron Microscopy

Volumn 35, Issue 2, 2002, Pages 68-80

  Razzaque, Mohammed S ^a,b   Taguchi, T ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Fibrogenic factors; Fibrosis; Interstitium; Kidney; Tubules

Indexed keywords

CYTOKINE; GLYCOPROTEIN; GROWTH FACTOR;

CONNECTIVE TISSUE; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; INFLAMMATORY CELL; KIDNEY FIBROSIS; PATHOLOGY; PRIORITY JOURNAL; REVIEW; WOUND HEALING;

EXTRACELLULAR MATRIX; FIBROBLASTS; FIBROSIS; HUMANS; KIDNEY DISEASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;

EID: 0036613962     PISSN: 09184287     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007950200009     Document Type: Review

References (150)

1. The pathogenesis of cutaneous fibrosis
2. Liver fibrosis, the hepatic stellate cell and tissue inhibitors of metalloproteinases
3. Role of myofibroblasts during normal tissue repair and excessive scarring: Interest of their assessment in nephropathies
4. Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury
5. Platelet-derived growth factor is chemotactic for fibroblasts
6. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing
7. Angiogenesis in wound healing
8. Growth regulation of skin fibroblasts
9. Tumor necrosis factor alpha induces invasiveness of human skin fibroblasts in vitro
10. Diminished interleukin-8 (IL-8) production in the fetal wound healing response
11. Fetal wound repair: Where do we go from here?
12. Epidermal integrin expression is upregulated rapidly in human fetal wound repair
13. Scarless healing. The fetal wound
14. Localization in situ of type VI collagen protein and its mRNA in mesangial proliferative glomerulonephritis using renal biopsy sections
15. Immunohistochemical localization of type I, III and IV (basement membrane) collagens in the liver
16. Appearance of denuded hepatic stellate cells and their subsequent myofibroblast-like transformation during the early stage of biliary fibrosis in the rat
17. Tissue and molecular events in human conjunctival scarring in ocular cicatricial pemphigoid
18. The pathogenesis of pulmonary fibrosis: Is there a fibrosis gene?
19. Pathogenesis and progression of human pancreatic fibrosis
20. Mechanisms of tissue repair: From wound healing to fibrosis
21. Identification of type VI collagen synthesizing cells in human diabetic glomerulosclerosis using renal biopsy sections
22. Mesangial myofibroblastic transformation in steroid-dependent minimal change nephrotic syndrome
23. Keloids and hypertrophic scars: A comprehensive review
24. Transforming growth factor-beta gene transfer to the lung induces myofibroblast presence and pulmonary fibrosis
25. Cytokines and pulmonary fibrosis
26. Interstitial collagen in alcoholic human liver
27. Estimating progression to cirrhosis in chronic hepatitis C virus infection
28. In situ localization of type III and type IV collagen-expressing cells in human diabetic nephropathy
29. The long-term prognosis of the primary glomerulonephritides. A morphological and clinical analysis of 1747 cases
30. Glomerular expression of type III and type IV collagens in benign nephrosclerosis: Immunohistochemical and in situ hybridization study
31. Biochemical assessment of myocardial fibrosis in hypertensive heart disease
32. Role of apoptosis in fibrogenesis
33. Expression of the heat shock protein 47 in gentamicin-treated rat kidneys
34. Mechanisms of bleomycin-induced lung damage
35. A light and electron microscopic analysis of gentamicin nephrotoxicity in rats
36. Localization of HSP47 in cisplatn-treated rat kidney: Possible role in tubulointerstitial damage
37. Characterization of inflammatory cells in autoimmune tubulointerstitial nephritis in rats
38. Expression of cell adhesion molecules in tubulointerstitial nephritis associated with Sjogren's syndrome
39. Regulation of interleukin-4 on collagen gene expression by systemic sclerosis fibroblasts in culture
40. IL-4 upregulates tenascin synthesis in scleroderma and healthy skin fibroblasts
41. Stimulation of sulphated glycosaminoglycan and decorin production in adult dermal fibroblasts by recombinant human interleukin-4
42. Interleukin-4 transgenic mice develop glomerulosclerosis independent of immunoglobulin deposition
43. Upregulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy
44. Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy
45. Osteopontin expression in progressive renal injury in remnant kidney: Role of angiotensin II
46. Osteopontin expressed by renal tubular epithelium mediates interstitial monocyte infiltration in rats
47. Tubular osteopontin expression in human glomerulonephritis and renal vasculitis
48. Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: A pathogenetic role in interstitial monocytes recruitment
49. Inhibition of monocyte chemoattractant protein-1 expression in tubular epithelium attenuates tubulointerstitial alteration in rat Goodpasture syndrome
50. Chemokine expression in experimental tubulointerstitial nephritis
51. Tubules are the major site of M-CSF production in experimental kidney disease: Correlation with local macrophage proliferation
52. Macrophage colony-stimulating-factor (M-CSF or CSF-1) and its receptor: Structure-function relationships
53. Expression of macrophage migration inhibitory factor in human glomerulonephritis
54. TNF-alpha up-regulates renal MIF expression in rat crescentic glomerulonephritis
55. Age-related nephropathy in the Fischer 344 rat is associated with overexpression of collagens and collagen-binding heat shock protein 47
56. Upregulation of heat shock protein 47 in the hypertensive kidney: Possible role in nephrovascular sclerotic process
57. The renal expression of heat shock protein 47 and collagens in acute and chronic experimental diabetes in rats
58. Molecular basis of renal fibrosis
59. Distribution and cellular origin of type III, type IV and type VI collagens in tubulointerstitial damage in various renal diseases
60. Significance of increased accumulation of type VI collagen and transforming growth factor beta 1 in tubulointerstitial damage in hypertensive nephrosclerosis: An immunohistochemical study
61. Immunohistochemical analysis of type III and IV collagens in tubulointerstitial damage in human benign nephrosclerosis
62. Specialized collagen mRNA and secreted collagens in human glomerular epithelial, mesangial, and tubular cells
63. Identification of cellular origin of type I collagen in glomeruli of rats with crescentic glomerulonephritis induced by anti-glomerular basement membrane antibody
64. The pathogenesis of cutaneous fibrosis
65. Regulation of connective tissue turnover by cellmatrix interactions
66. Analysis of the acute and chronic wound environments: The role of proteases and their inhibitors
67. Changes in matrix metalloproteinases during the evolution of interstitial renal fibrosis in a rat experimental model
68. Tissue inhibitor of the metalloproteinases and renal extracellular matrix accumulation
69. Extracellular matrix accumulation in immune-mediated tubulointerstitial injury
70. Inhibition of the matrix metalloproteinase system in a rat model of chronic cyclosporine nephropathy
71. TIMP-1 deficiency does not attenuate interstitial fibrosis in obstructive nephropathy
72. Metalloprotease-disintegrins: Links to cell adhesion and cleavage of TNFα and notch
73. ADAMs and cell fusion
74. ADAM-TS5, ADAM-TS6, and ADAM-TS7, novel members of a new family of zinc metalloproteases. General features and genomic distribution of the ADAM-TS family
75. Extracellular matrix regulates and L-ascorbic acid 2-phosphate further modulates morphology, proliferation, and collagen synthesis of perisinusoidal stellate cells
76. Expression and function of integrin receptors for collagen and laminin in cultured human hepatic stellate cells
77. Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis
78. Fibroblast matrix gene expression and connective tissue remodeling: Role of endothelin-1
79. The possible role of colligin/HSP47, a collagen-binding protein, in the pathogenesis of human and experimental fibrotic diseases
80. How cells read TGF-beta signals
81. The transforming growth factor-betas: Structure, signaling, and roles in nervous system development and functions
82. Transforming growth factor-beta as a target for treatment in diabetic nephropathy
83. A novel model to study renal myofibroblast formation in vitro
84. TGF-beta and regulation of interstitial nephritis
85. The role of transforming growth factor beta in chronic renal allograft nephropathy
86. Altered expression of transforming growth factor-βs in chronic renal rejection
87. Transforming growth factor-beta 1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction
88. Inhibition of TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis
89. Connective tissue growth factor: A mediator of TGF-beta action on fibroblasts
90. Inhibition of TGF-beta-stimulated CTGF gene expression and anchorage-independent growth by cAMP identifies a CTGF-dependent restriction point in the cell cycle
91. A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene
92. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair
93. Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients
94. Connective tissue growth factor: Just another factor in renal fibrosis?
95. Connective tissue growth factor: Potential role in glomerulosclerosis and tubulointerstitial fibrosis
96. Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease
97. Coexpression of endothelin-converting enzyme-1 and endothelin-1 in different stages of human atherosclerosis
98. Pulmonary fibrosis and chronic lung inflammation in ET-1 transgenic mice
99. Characterization of the enzyme involved in the processing of big endothelin-1 in human lung epithelial cells
100. Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis
101. FTS reduces bleomycin-induced cytokine and chemokine production and inhibits pulmonary fibrosis in mice
102. Dexamethasone inhibits stimulation of pulmonary endothelins by proinflammatory cytokines: Possible involvement of a nuclear factor kappa B dependent mechanism
103. Elevated expression of endothelin-1 and endothelin-converting enzyme-1 in idiopathic pulmonary fibrosis: Possible involvement of proinflammatory cytokines
104. Increased levels of endothelin-1 in bronchoalveolar lavage fluid from patients with systemic sclerosis contribute to fibroblast mitogenic activity in vitro
105. Prevention of chronic renal allograft rejection in rats with an oral endothelin A receptor antagonist
106. Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension
107. Expression and function of heat shock protein 47: A collagen-specific molecular chaperone in the endoplasmic reticulum
108. Coexpression of collagens and collagen-binding heat shock protein 47 in human diabetic nephropathy and IgA nephropathy
109. Upregulation of HSP47 and collagen type III in the dermal fibrotic disease, keloid
110. Bleomycin-induced pulmonary fibrosis in rat is associated with increased expression of collagen-binding heat shock protein (HSP) 47
111. Coexpression of the collagen-binding stress protein HSP47 gene and the alpha 1(I) and alpha 1(III) collagen genes in carbon tetrachloride induced rat liver fibrosis
112. Collagen-binding heat shock protein (HSP) 47 expression in anti-thymocyte serum (ATS)induced glomerulonephritis
113. Life-long dietary restriction modulates the expression of collagens and collagen-binding heat shock protein 47 in aged Fischer 344 rat kidney
114. Antisense oligonucleotides against collagenbinding stress protein HSP47 suppress collagen accumulation in experimental glomerulonephritis
115. The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis
116. Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy
117. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction
118. Renal interstitial fibrosis is reduced in angiotensin II type la receptor-deficient mice
119. Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice
120. An interleukin-1 receptor antagonist decreases fibrosis induced by dimethylnitrosamine in rat liver
121. Modulation of antibody-mediated glomerular injury in vivo by IL-Ira, soluble IL-1 receptor, and soluble TNF receptor
122. In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: A potential new therapy for hepatic fibrosis
123. PDGF receptor kinase blocker AG1295 attenuates interstitial fibrosis in rat kidney after unilateral obstruction
124. Quantification of TGF-betal mRNA along rat nephron in obstructive nephropathy
125. Increased expression of TGF-beta1 but not of its receptors contributes to human obstructive nephropathy
126. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease
127. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney
128. Expression of decorin, biglycan, and collagen type I in human renal fibrosing disease
129. Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters
130. Preventive effect of pirfenidone against experimental sclerosing peritonitis in rats
131. Pirfenidone improves renal function and fibrosis in the post-obstructed kidney
132. Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis
133. Antifibrotic therapy for the treatment of pulmonary fibrosis
134. Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: Results of a prospective, open-label Phase II study
135. Inhibition of collagen synthesis with prolyl 4-hydroxylase inhibitor improves left ventricular function and alters the pattern of left ventricular dilatation after myocardial infarction
136. Intra- and extracellular enzymes of collagen biosynthesis as biological and chemical targets in the control of fibrosis
137. Selective inhibition of hepatic collagen accumulation in experimental liver fibrosis in rats by a new prolyl 4-hydroxylase inhibitor
138. Caloric restriction and experimental carcinogenesis
139. The anti-carcinogenic effects of dietary restriction: Mechanisms and future directions
140. Chronic dietary restriction and longevity
141. Longevity-assurance mechanisms and caloric restriction
142. Caloric intake and longevity
143. Protein restriction in the pre-end-stage renal disease (ESRD) patient: Who, when, how, and the effect on subsequent ESRD outcome
144. Dietary protein restriction and the progression of chronic renal disease: What have all of the results of the MDRD study shown?
145. Use of tetrandrine to differentiate between mechanisms involved in silica- versus bleomycin-induced fibrosis
146. Inhibitory action of tetrandrine on macrophage production of interleukin-1 (IL-1)-like activity and thymocyte proliferation
147. Scleroderma treated with the diethylaminoethylester hydriodide salt of penicillin G
148. Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor
149. TNF-alpha inactivation of collagen receptors: IMplications for fibroblast function and fibrosis
150. Transient exposure to tumor necrosis factor-alpha inhibits collagen accumulation by cultured hypertrophic scar fibroblasts